CST1
Cystatin-SN
Also known as: CYTN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01037
- Gene
- CST1
- Ensembl
- ENSG00000170373
- Chromosome
- 20
- Canonical length
- 141 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes a cysteine proteinase inhibitor found in saliva, tears, urine, and seminal fluid. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
141 residues, UniProt reviewed canonical sequence.
>P01037|CST1
1 MAQYLSTLLL LLATLAVALA WSPKEEDRII PGGIYNADLN DEWVQRALHF AISEYNKATK
61 DDYYRRPLRV LRARQQTVGG VNYFFDVEVG RTICTKSQPN LDTCAFHEQP ELQKKQLCSF
121 EIYEVPWENR RSLVKSRCQE SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CST1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 26,682 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 26,682 nTPM
- gallbladder: 224 nTPM
- pancreas: 35 nTPM
- prostate: 12 nTPM
- heart muscle: 7.5 nTPM
- placenta: 3.8 nTPM
Single-cell type
- salivary acinar cells: 2,359 nCPM
- lacrimal acinar cells: 899 nCPM
- endometrial glandular cells: 39 nCPM
- prostatic glandular cells: 34 nCPM
- salivary duct cells: 22 nCPM
- epididymal efferent duct absorptive cells: 9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 2.9 nTPM
- medulla oblongata: 1.4 nTPM
- midbrain: 1.2 nTPM
- spinal cord: 0.6 nTPM
- white matter: 0.6 nTPM
- cerebral cortex: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.2
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CST1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CST1 as an antibody target. Whether an autoantibody or antibody against CST1 could matter depends on whether native CST1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CST1 is annotated as secreted, so native CST1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CST1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...